Follow the SyntheticMR AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, SyntheticMR AB has published 1 insider filings. Market capitalisation: €51.8m. The latest transaction was reported on 3 July 2025 (Sale). Among the most active insiders: Jan Bertus Marten Warntjes. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
SyntheticMR AB es una empresa centrada en el desarrollo de soluciones de imágenes médicas. Cotiza en el mercado XSTO.